Key facts
- This page summarizes Chee Kong Choo's Form 3 filing for CytoMed Therapeutics Ltd (GDTC).
- 0 reported transactions and 0 derivative rows are listed below.
- Accepted by SEC: 15 May 2026, 09:00.
Key filing fact
Ownership activity is grounded in SEC Form 3 disclosures.
Shares, units, or other non-derivative securities reported in this filing.
No transaction description listed
No transaction description listed
No transaction description listed
Additional SEC filing notes
Footnote F1
3,773,291 Ordinary Shares is presently held by Glorious Finance Limited ("Glorious Finance"). CHOO Chee Kong ("Mr. Choo") owns 55.0% of shares in Glorious Finance and has beneficial ownership of 2,075,310 Ordinary Shares. Mr. Choo disclaims beneficial ownership of 1,697,981 Ordinary Shares held by Glorious Finance to the extent that he does not have an economic interest therein;
Footnote F2
194,112 Ordinary Shares held by EP Capital Inc. ("EP Capital"). Mr. Choo is deemed to beneficially own the 194,112 Ordinary Shares held by EP Capital, and
Footnote F3
318,324 Ordinary Shares held directly by Mr. Choo.